 Novo Nordisk said Thursday it will spend 1.1 billion to acquire Forma in a deal that sent biotech stock Forma flying. The post Novo Nordisk Jumps Into Sickle Cell Fray With 1.1 Billion Forma Therapeutics Buyout appeared first on Investors Business Daily. 